Contract Research

Contact Us
Tergene's upcoming GMP facility


  • Once completed, Tergene would have a manufacturing facility as per US FDA specifications.

  • The suite will have up to 1000 L of fermentation capacity besides state of the art down stream equipments and purifications systems. The suite will have the necessary support areas.

  • A formulation and fill-finish facility for liquid and lyophilized vials. A syringe filling unit (PFS) is also considered as part of this suite. Separate packaging area is attached to this suite.

  • Centralized ware housing facility for raw materials and finished goods with prescribed level of segregations. Separate sampling and dispensing booths for sterile and non sterile materials.

  • Centralized quality control laboratory with adequate instrumentation support for raw material and finished products testing. Dedicated sterility testing areas for liquid and lyophilized powders.

  • Common ETP facility for liquid waste disposal and an incinerator for solid waste disposal will be built as per central pollution control department. All bio waste generated in the process will be thermally inactivated prior to treatment.


 Disclaimer          Environment and Health Risk Management Plan            2018 All Rights Reserved with Tergene Biotech